概括
动脉样硬化涉及由于CD47增加而导致疾病细胞的移除受损. 阻断CD47恢复细胞清除并减少小鼠模型中的动脉样硬化,显示出潜在的治疗点.
科学领域:
- 心血管生物学
- 免疫学
- 细胞病理
背景情况:
- 动脉样硬化, 心脏病发作和中风的基础, 具有病态的血管细胞和碎片的积累.
- 这些细胞在动脉样硬化中缺乏有效清除的机制尚不清楚.
- 在动脉生成过程中观察到抗细胞分子CD47的升级.
研究的目的:
- 研究CD47在动脉生成过程中受损血管细胞清除中的作用.
- 确定针对CD47可以改善动脉样硬化.
- 在血管疾病中识别受损血细胞的驱动因素.
主要方法:
- 在动脉硬化小鼠模型中使用CD47阻断抗体.
- 评估病变血管细胞的细胞移除 (编程细胞移除).
- 涉及TNF-α在受损的细胞效应的机制研究.
主要成果:
- 阻断CD47的抗体逆转了细胞分裂的缺陷.
- 疾病血管组织的清除正常化.
- 动脉样硬化在多个小鼠模型中得到改善.
- 在血管疾病中,TNF-α被确定为受损的编程细胞去除的驱动因素.
结论:
- 由CD47升高调节和潜在的TNF-α驱动的受损血细胞形成,在动脉样硬化中起病原作用.
- CD47是一种新的心血管疾病治疗点.
- 这种缺陷是不固定的,可以逆转.
相关概念视频
Inflammation
63.8K
Overview
63.8K
Atherosclerosis III: Management
567
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Phagocytosis of Apoptotic Cells
5.5K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
5.5K
Atherosclerosis I: Introduction
1.8K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K
Coronary Artery Disease I: Introduction
1.5K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Coronary Artery Disease IV: Preventive Measures
813
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
813


